Literature DB >> 15786467

Multiple regions of alpha-synuclein are associated with Parkinson's disease.

Jakob C Mueller1, Julia Fuchs, Anne Hofer, Alexander Zimprich, Peter Lichtner, Thomas Illig, Daniela Berg, Ullrich Wüllner, Thomas Meitinger, Thomas Gasser.   

Abstract

alpha-Synuclein is considered to play an important role in the pathogenesis of both the rare familial and the common sporadic forms of Parkinson's disease. Previous reports primarily have tested the association of alpha-synuclein promoter polymorphisms with idiopathic Parkinson's disease, but results are controversial. We first characterized the linkage disequilibrium structure of the alpha-synuclein gene region with a dense set of 56 genetic markers and subsequently performed two independent case-control association analyses using tagging markers. We could distinguish two large linkage disequilibrium blocks spanning the alpha-synuclein gene. Several markers within the 3'-block around exons 5 and 6 showed strong association with Parkinson's disease (p = 0.00009). Effects of the associated variants might be mediated by regulatory elements in this highly conserved region or by a frequency shift in a previously described splice variant lacking exon 5. A direct association with promoter polymorphisms could not be replicated in our sample set. A second set of markers in the 5'-block of the gene were also significantly associated with Parkinson's disease, when young patients and female subjects were analyzed separately. These findings indicate locus heterogeneity for the pathogenesis of Parkinson's disease in different genetic or physiological environments, related to sex and age.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15786467     DOI: 10.1002/ana.20438

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  82 in total

1.  Age at onset in LRRK2-associated PD is modified by SNCA variants.

Authors:  Teresa Botta-Orfila; Mario Ezquerra; Pau Pastor; Rubén Fernández-Santiago; Claustre Pont-Sunyer; Yaroslau Compta; Oswaldo Lorenzo-Betancor; Lluis Samaranch; Maria José Martí; Francesc Valldeoriola; Matilde Calopa; Manel Fernández; Miquel Aguilar; Oriol de Fabregas; Jorge Hernández-Vara; Eduard Tolosa
Journal:  J Mol Neurosci       Date:  2012-06-06       Impact factor: 3.444

2.  A search for SNCA 3' UTR variants identified SNP rs356165 as a determinant of disease risk and onset age in Parkinson's disease.

Authors:  Lucía F Cardo; Eliecer Coto; Lorena de Mena; René Ribacoba; Oswaldo Lorenzo-Betancor; Pau Pastor; Lluis Samaranch; Ignacio F Mata; Marta Díaz; Germán Moris; Manuel Menéndez; Ana I Corao; Victoria Alvarez
Journal:  J Mol Neurosci       Date:  2011-11-11       Impact factor: 3.444

3.  SNCA variant associated with Parkinson disease and plasma alpha-synuclein level.

Authors:  Ignacio F Mata; Min Shi; Pinky Agarwal; Kathryn A Chung; Karen L Edwards; Stewart A Factor; Douglas R Galasko; Carmen Ginghina; Alida Griffith; Donald S Higgins; Denise M Kay; Hojoong Kim; James B Leverenz; Joseph F Quinn; John W Roberts; Ali Samii; Katherine W Snapinn; Debby W Tsuang; Dora Yearout; Jing Zhang; Haydeh Payami; Cyrus P Zabetian
Journal:  Arch Neurol       Date:  2010-11

4.  Association of SNCA with Parkinson: replication in the Harvard NeuroDiscovery Center Biomarker Study.

Authors:  Hongliu Ding; Alison K Sarokhan; Sarah S Roderick; Rachit Bakshi; Nancy E Maher; Paymon Ashourian; Caroline G Kan; Sunny Chang; Andrea Santarlasci; Kyleen E Swords; Bernard M Ravina; Michael T Hayes; U Shivraj Sohur; Anne-Marie Wills; Alice W Flaherty; Vivek K Unni; Albert Y Hung; Dennis J Selkoe; Michael A Schwarzschild; Michael G Schlossmacher; Lewis R Sudarsky; John H Growdon; Adrian J Ivinson; Bradley T Hyman; Clemens R Scherzer
Journal:  Mov Disord       Date:  2011-09-23       Impact factor: 10.338

5.  SNCA 3'UTR genetic variants in patients with Parkinson's disease and REM sleep behavior disorder.

Authors:  M Toffoli; E Dreussi; E Cecchin; M Valente; N Sanvilli; M Montico; S Gagno; M Garziera; M Polano; M Savarese; G Calandra-Buonaura; F Placidi; M Terzaghi; G Toffoli; G L Gigli
Journal:  Neurol Sci       Date:  2017-04-13       Impact factor: 3.307

6.  Polymorphisms in the proteasomal subunit alpha4 are not associated with Parkinson's disease.

Authors:  C B Lücking; P Lichtner; M Dichgans; T Illig; C Gieger; D Berg; T Gasser
Journal:  J Neurol       Date:  2008-03-14       Impact factor: 4.849

7.  The genetic contributions of SNCA and LRRK2 genes to Lewy Body pathology in Alzheimer's disease.

Authors:  Colton Linnertz; Michael W Lutz; John F Ervin; Jawara Allen; Natalie R Miller; Kathleen A Welsh-Bohmer; Allen D Roses; Ornit Chiba-Falek
Journal:  Hum Mol Genet       Date:  2014-04-28       Impact factor: 6.150

8.  Genetic analysis of α-synuclein 3' untranslated region and its corresponding microRNAs in relation to Parkinson's disease compared to dementia with Lewy bodies.

Authors:  Lidia Tagliafierro; Omolara-Chinue Glenn; Madison E Zamora; Thomas G Beach; Randy L Woltjer; Michael W Lutz; Ornit Chiba-Falek
Journal:  Alzheimers Dement       Date:  2017-04-18       Impact factor: 21.566

9.  Aggregates assembled from overexpression of wild-type alpha-synuclein are not toxic to human neuronal cells.

Authors:  Li-Wen Ko; Hwai-Hwa C Ko; Wen-Lang Lin; Jayanranyan G Kulathingal; Shu-Hui C Yen
Journal:  J Neuropathol Exp Neurol       Date:  2008-11       Impact factor: 3.685

10.  Calbindin 1, fibroblast growth factor 20, and alpha-synuclein in sporadic Parkinson's disease.

Authors:  Ikuko Mizuta; Tatsuhiko Tsunoda; Wataru Satake; Yuko Nakabayashi; Masahiko Watanabe; Atsushi Takeda; Kazuko Hasegawa; Kenji Nakashima; Mitsutoshi Yamamoto; Nobutaka Hattori; Miho Murata; Tatsushi Toda
Journal:  Hum Genet       Date:  2008-06-22       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.